Achaogen, Inc.: Clinical Trials

12 trials sponsored by Achaogen, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 terminated. 9 Phase 1, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 8, Terminated 1
Phase 32Completed 2
Phase 21Completed 1

Follow Achaogen, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
plazomicin, metformin - Healthy Volunteers
Phase 1CompletedAchaogen, Inc.162017-08-312017-10-11
A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin
[14C]-plazomicin - Healthy Volunteers
Phase 1CompletedAchaogen, Inc.62017-06-162017-07-12
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789
ACHN-383, ACHN-789, Placebo - Healthy Volunteers
Phase 1CompletedAchaogen, Inc.402017-05-172017-12-02
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
plazomicin, meropenem, levofloxacin (oral) - Complicated Urinary Tract Infection, Acute Pyelonephritis
Phase 3CompletedAchaogen, Inc.6092016-01-112018-08-23
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
plazomicin, colistin, meropenem - Bloodstream Infections (BSI) Due to CRE, Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE
Phase 3CompletedAchaogen, Inc.692014-09-162018-10-16
A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
ACHN-975, placebo - Healthy Volunteer
Phase 1TerminatedAchaogen, Inc.42013-05-012013-07-01
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
ACHN-975, placebo - Healthy Volunteer
Phase 1CompletedAchaogen, Inc.502012-05-012013-01-21
A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers
ACHN-490 Injection, Moxifloxacin, Placebo - Cardiac Effects in Normal Healthy Volunteers
Phase 1CompletedAchaogen, Inc.642011-10-012012-05-09
PK Study of ACHN-490 Injection in Renally Impaired Subjects
ACHN-490 Injection - Renal Insufficiency
Phase 1CompletedAchaogen, Inc.242011-09-012012-08-23
A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
levofloxacin, plazomicin, placebo - Complicated Urinary Tract Infection, Acute Pyelonephritis
Phase 2CompletedAchaogen, Inc.1452010-07-132018-08-22
Phase 1 Study to Determine Safety, Blood PK and Lung Penetration
ACHN-490 Injection, Placebo (normal saline) - Healthy Volunteers
Phase 1CompletedAchaogen, Inc.402010-01-012012-02-27
Phase 1 Study for Safety of ACHN-490
ACHN-490 Injection vs placebo - Healthy
Phase 1CompletedAchaogen, Inc.392009-01-012012-02-27

Conditions studied

Bacterial Infections (2)  ·  Pneumonia (1)  ·  Pyelonephritis (1)  ·  Renal Insufficiency (1)  ·  Sepsis (1)  ·  Urinary Tract Infections (1)

Interventions

plazomicin (7)  ·  ACHN-975 (2)  ·  Levofloxacin (2)  ·  Meropenem (2)  ·  Colistin (1)  ·  Metformin (1)  ·  Moxifloxacin (1)  ·  Saline Solution (1)  ·  Tigecycline (1)  ·  colistinmethanesulfonic acid (1)

Countries

United States (6)  ·  Australia (1)

Top investigators

Lynn E Connolly, MD, PhD (2)  ·  Shyeilla Dhuria (2)  ·  Carter Brooks, MD (1)  ·  Daniel J Cloutier, PharmD (1)  ·  Nancy A Havrilla, MS, RN (1)

Results publications

PMID 30275092, PMID 30605260, PMID 30650259, PMID 30786187, PMID 31254273

NIH funding

2015 (1)